Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fenske

Showing results (1091-1100 of 1,142) with videos related to

Pageof 115
Sort By:
Blood|September 26, 2012
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?Ulrike Bacher, Evgeny Klyuchnikov, Jennifer Le-Rademacher, et al.
JAMA Oncology|March 1, 2019
Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMTAbraham S Kanate, Ambuj Kumar, Peter Dreger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 6, 2023
Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical TrialsJoanna M Streck, Ju-Whei Lee, Angela Wangari Walter, et al.
Cell Reports|June 28, 2016
Decreased Consumption of Branched-Chain Amino Acids Improves Metabolic HealthLuigi Fontana, Nicole E Cummings, Sebastian I Arriola Apelo, et al.
British Journal of Haematology|March 19, 2016
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantationTimothy S Fenske, Kwang W Ahn, Tara M Graff, et al.
Der Urologe. Ausg. A|July 10, 2013
[Postoperative prognosis of chromophobic renal cell carcinoma: comparative analysis of the multinational CORONA database]M May, R Zigeuner, A Aziz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphomaSonali M Smith, Linda J Burns, Koen van Besien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2013
Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modalityTimothy S Fenske, Mei-Jie Zhang, Jeanette Carreras, et al.
Cancer|July 28, 2017
C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapyNarendranath Epperla, Kami J Maddocks, Mohammed Salhab, et al.
American Journal of Hematology|November 24, 2016
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapiesLuciano J Costa, Kami Maddocks, Narendranath Epperla, et al.
Pageof 115

Showing results (1091-1100 of 1,142) with videos related to

Sort By:
Pageof 115
Blood|September 26, 2012
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?Ulrike Bacher, Evgeny Klyuchnikov, Jennifer Le-Rademacher, et al.
JAMA Oncology|March 1, 2019
Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMTAbraham S Kanate, Ambuj Kumar, Peter Dreger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 6, 2023
Cigarette and Alternative Tobacco Product Use among Adult Cancer Survivors Enrolled in 9 ECOG-ACRIN Clinical TrialsJoanna M Streck, Ju-Whei Lee, Angela Wangari Walter, et al.
Cell Reports|June 28, 2016
Decreased Consumption of Branched-Chain Amino Acids Improves Metabolic HealthLuigi Fontana, Nicole E Cummings, Sebastian I Arriola Apelo, et al.
British Journal of Haematology|March 19, 2016
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantationTimothy S Fenske, Kwang W Ahn, Tara M Graff, et al.
Der Urologe. Ausg. A|July 10, 2013
[Postoperative prognosis of chromophobic renal cell carcinoma: comparative analysis of the multinational CORONA database]M May, R Zigeuner, A Aziz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphomaSonali M Smith, Linda J Burns, Koen van Besien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 18, 2013
Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modalityTimothy S Fenske, Mei-Jie Zhang, Jeanette Carreras, et al.
Cancer|July 28, 2017
C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapyNarendranath Epperla, Kami J Maddocks, Mohammed Salhab, et al.
American Journal of Hematology|November 24, 2016
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapiesLuciano J Costa, Kami Maddocks, Narendranath Epperla, et al.
Pageof 115